Phoenix AZ 前列腺癌临床试验
17项针对 前列腺癌的研究正在 Phoenix及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Mayo Clinic Hospital in Arizona, Phoenix
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Phoenix
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
招募中1/2 期
- GSK Investigational Site, Phoenix
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Phoenix
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
招募中3 期
- Mayo Clinic- Phoenix, Phoenix
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Cancer Center at Saint Joseph's, Phoenix
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Phoenix
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Mayo Clinic, Phoenix
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Mayo Clinic, Phoenix
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
招募中2 期
- Mayo Clinic in Arizona, Phoenix
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Mayo Clinic, Phoenix
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Cancer Center at Saint Joseph's, Phoenix
Understanding of Genetics by Men at Risk for Prostate Cancer
招募中欢迎健康志愿者
- Mayo Clinic, Phoenix
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA60 项研究
- St. Louis, MO47 项研究
- San Francisco, CA45 项研究
- Chicago, IL45 项研究
- Philadelphia, PA44 项研究
- Seattle, WA44 项研究
- Nashville, TN43 项研究
- Baltimore, MD42 项研究
- Washington, DC38 项研究
Phoenix的其他研究
- 结直肠癌25 项研究
- 乳腺癌25 项研究
- 肥胖症23 项研究
- 转移性癌症20 项研究
- 非小细胞肺癌20 项研究
- 心力衰竭18 项研究
- 癌症（所有类型）17 项研究
- 胰腺癌17 项研究
- 多发性骨髓瘤16 项研究
- 心血管疾病16 项研究
- 超重15 项研究
- 阿尔茨海默病15 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月2日。每项研究自行设定入选标准，由研究团队决定谁能参与。